1. Company Directors - P
2. Pernock David

Insider Trading History of Pernock David

The following table details the insider trading activities (stock purchases, stock sales, and stock option exercises) by Pernock David since 2013. The trader's CIK number is 1471956. At the time of the last reporting, Pernock David was the Chief Executive Officer of Eagle Pharmaceuticals, Inc.. (stock ticker symbol EGRX). Also see all insider trading activities at Eagle Pharmaceuticals, Inc..

Note that in the past Pernock David also reported insider trading activities as an insider of the following companies:

Yearly summary of insider trading at Fibrocell Science, Inc. (FCSC) by Pernock David

		Insider Buying		Insider Sales		Option Exercises
Year	Symbol	Shares	Value	Shares	Value	Shares	Value
2016	FCSC	50,000	$46,100	0	$0	0	$0
2015	FCSC	23,100	$109,166	0	$0	0	$0
2014	FCSC	22,500	$62,210	0	$0	0	$0
2013	FCSC	10,000	$36,900	0	$0	0	$0

Yearly summary of insider trading at Eagle Pharmaceuticals, Inc. (EGRX) by Pernock David

		Insider Buying		Insider Sales		Option Exercises
Year	Symbol	Shares	Value	Shares	Value	Shares	Value
2017	EGRX	966	$76,918	0	$0	0	$0

Insider trading activities at 2 companies by Pernock David:

1. Fibrocell Science, Inc. (FCSC)

2. Eagle Pharmaceuticals, Inc. (EGRX)

Table 1. Insider trading of Fibrocell Science, Inc. (FCSC) by Pernock David

Trade Date	Symbol	Trade Type	Shares	Price ($)	Value ($)
2016-12-02	FCSC	Buy	50,000	.92	46,100
2015-11-13	FCSC	Buy	3,000	5.00	14,996
2015-08-11	FCSC	Buy	3,500	6.54	22,890
2015-05-13	FCSC	Buy	16,600	4.29	71,280
2014-12-12	FCSC	Buy	5,000	2.52	12,600
2014-11-20	FCSC	Buy	5,000	2.54	12,685
2014-06-05	FCSC	Buy	12,500	2.95	36,925
2013-11-21	FCSC	Buy	10,000	3.69	36,900

Table 2. Insider trading of Eagle Pharmaceuticals, Inc. (EGRX) by Pernock David

Trade Date	Symbol	Trade Type	Shares	Price ($)	Value ($)
2017-05-19	EGRX	Buy	255	79.69	20,320
2017-05-16	EGRX	Buy	200	82.24	16,448
2017-03-21	EGRX	Buy	61	83.98	5,122
2017-03-09	EGRX	Buy	450	77.84	35,028

Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Pernock David (Chief Executive Officer of Eagle Pharmaceuticals, Inc. at the time of this reporting) see the Securities and Exchange Commission (SEC) website.

▪ Real-time Insider Trading

▪ Insider Officer Cluster Trading

▪ Top Officer Buys of the Week

▪ Top Officer Buys of the Month